3 news items
Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial and Corporate Activities
KA
15 May 24
; the timing of any planned investigational new drug application or new drug application; the risk of cessation or delay of any ongoing or planned clinical
Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial
KA
8 Apr 24
of the availability of data from Kineta's clinical trials; the timing of any planned investigational new drug application or new drug application; the risk
Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update
KA
21 Mar 24
; the timing of any planned investigational new drug application or new drug application; the risk of cessation or delay of any ongoing or planned clinical
- Prev
- 1
- Next